| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications[J]. Med Res Rev, 2022, 42(1): 259-305. DOI: 10.1002/med.21817.
|
| [6] |
Jurcau A, Simion A. Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies[J]. Int J Mol Sci, 2021, 23(1): 14. DOI: 10.3390/ijms23010014.
|
| [7] |
Jurcau A, Ardelean IA. Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke[J]. J Integr Neurosci, 2021, 20(3): 727-744. DOI: 10.31083/j.jin2003078.
|
| [8] |
|
| [9] |
Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review[J]. JAMA, 2021, 325(11): 1088-1098. DOI: 10.1001/jama.2020.26867.
|
| [10] |
|
| [11] |
Orellana-Urzúa S, Rojas I, Líbano L, et al. Pathophysiology of ischemic stroke: role of oxidative stress[J]. Curr Pharm Des, 2020, 26(34): 4246-4260. DOI: 10.2174/1381612826666200708133912.
|
| [12] |
Qin C, Yang S, Chu YH, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions[J]. Signal Transduct Target Ther, 2022, 7(1): 215. DOI: 10.1038/s41392-022-01064-1.
|
| [13] |
O'Rourke SA, Shanley LC, Dunne A. The Nrf2-HO-1 system and inflammaging[J]. Front Immunol, 2024, 15: 1457010. DOI: 10.3389/fimmu.2024.1457010.
|
| [14] |
Suzuki T, Takahashi J, Yamamoto M. Molecular basis of the KEAP1-NRF2 signaling pathway[J]. Mol Cells, 2023, 46(3): 133-141. DOI: 10.14348/molcells.2023.0028.
|
| [15] |
Murakami S, Kusano Y, Okazaki K, et al. NRF2 signalling in cytoprotection and metabolism[J]. Br J Pharmacol, 2023: 1-14. DOI: 10.1111/bph.16246.
|
| [16] |
Wang L, Zhang X, Xiong X, et al. Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke[J]. Antioxidants (Basel), 2022, 11(12): 2377. DOI: 10.3390/antiox11122377.
|
| [17] |
Varady KA, Cienfuegos S, Ezpeleta M, et al. Clinical application of intermittent fasting for weight loss: progress and future directions[J]. Nat Rev Endocrinol, 2022, 18(5): 309-321. DOI: 10.1038/s41574-022-00638-x.
|
| [18] |
Dutzmann J, Kefalianakis Z, Kahles F, et al. Intermittent fasting after ST-segment-elevation myocardial infarction improves left ventricular function: the randomized controlled INTERFAST-MI trial[J]. Circ Heart Fail, 2024, 17(5): e010936. DOI: 10.1161/circheartfailure.123.010936.
|
| [19] |
Teong XT, Liu K, Vincent AD, et al. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial[J]. Nat Med, 2023, 29(4): 963-972. DOI: 10.1038/s41591-023-02287-7.
|
| [20] |
Kapogiannis D, Manolopoulos A, Mullins R, et al. Brain responses to intermittent fasting and the healthy living diet in older adults[J]. Cell Metab, 2024, 36(8): 1668-1678.e5. DOI: 10.1016/j.cmet.2024.05.017.
|
| [21] |
Hansen B, Roomp K, Ebid H, et al. Perspective: the impact of fasting and caloric restriction on neurodegenerative diseases in humans[J]. Adv Nutr, 2024, 15(4): 100197. DOI: 10.1016/j.advnut.2024.100197.
|
| [22] |
Dai S, Wei J, Zhang H, et al. Intermittent fasting reduces neuroinflammation in intracerebral hemorrhage through the Sirt3/Nrf2/HO-1 pathway[J]. J Neuroinflammation, 2022, 19(1): 122. DOI: 10.1186/s12974-022-02474-2.
|
| [23] |
Sun YY, Zhu HJ, Zhao RY, et al. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice[J]. Redox Biol, 2023, 66: 102852. DOI: 10.1016/j.redox.2023.102852.
|
| [24] |
Cen M, Ouyang W, Zhang W, et al. MitoQ protects against hyperpermeability of endothelium barrier in acute lung injury via a Nrf2-dependent mechanism[J]. Redox Biol, 2021, 41: 101936. DOI: 10.1016/j.redox.2021.101936.
|
| [25] |
Xing G, Meng L, Cao S, et al. PPARα alleviates iron overload-induced ferroptosis in mouse liver[J]. EMBO Rep, 2022, 23(8): e52280. DOI: 10.15252/embr.202052280.
|
| [26] |
Ajoolabady A, Wang S, Kroemer G, et al. Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics[J]. Pharmacol Ther, 2021, 225: 107848. DOI: 10.1016/j.pharmthera.2021.107848.
|
| [27] |
Nguyen TN, Abdalkader M, Fischer U, et al. Endovascular management of acute stroke[J]. Lancet, 2024, 404(10459): 1265-1278. DOI: 10.1016/s0140-6736(24)01410-7.
|
| [28] |
Strilbytska O, Klishch S, Storey KB, et al. Intermittent fasting and longevity: from animal models to implication for humans[J]. Ageing Res Rev, 2024, 96: 102274. DOI: 10.1016/j.arr.2024.102274.
|
| [29] |
de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease[J]. N Engl J Med, 2019, 381(26): 2541-2551. DOI: 10.1056/NEJMra1905136.
|
| [30] |
Calabrese EJ, Kozumbo WJ. The hormetic dose-response mechanism: Nrf2 activation[J]. Pharmacol Res, 2021, 167: 105526. DOI: 10.1016/j.phrs.2021.105526.
|
| [31] |
Madkour MI, T El-Serafi A, Jahrami HA, et al. Ramadan diurnal intermittent fasting modulates SOD2, TFAM, Nrf2, and sirtuins (SIRT1, SIRT3) gene expressions in subjects with overweight and obesity[J]. Diabetes Res Clin Pract, 2019, 155: 107801. DOI: 10.1016/j.diabres.2019.107801.
|
| [32] |
Kumar A, Karuppagounder SS, Chen Y, et al. 2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer's resilience[J]. Neuron, 2023, 111(18): 2831-2846.e10. DOI: 10.1016/j.neuron.2023.06.013.
|
| [33] |
Jeong S, Chokkalla AK, Davis CK, et al. Circadian-dependent intermittent fasting influences ischemic tolerance and dendritic spine remodeling[J]. Stroke, 2024, 55(8): 2139-2150. DOI: 10.1161/strokeaha.124.046400.
|
| [34] |
Zhou H, Yan L, Huang H, et al. Tat-NTS peptide protects neurons against cerebral ischemia-reperfusion injury via ANXA1 SUMOylation in microglia[J]. Theranostics, 2023, 13(15): 5561-5583. DOI: 10.7150/thno.85390.
|
| [35] |
Hong Y, Liu Q, Peng M, et al. High-frequency repetitive transcranial magnetic stimulation improves functional recovery by inhibiting neurotoxic polarization of astrocytes in ischemic rats[J]. J Neuroinflammation, 2020, 17(1): 150. DOI: 10.1186/s12974-020-01747-y.
|
| [36] |
|
| [37] |
Forrester SJ, Kikuchi DS, Hernandes MS, et al. Reactive oxygen species in metabolic and inflammatory signaling[J]. Circ Res, 2018, 122(6): 877-902. DOI: 10.1161/circresaha.117.311401.
|
| [38] |
Elias A, Padinjakara N, Lautenschlager NT. Effects of intermittent fasting on cognitive health and Alzheimer's disease[J]. Nutr Rev, 2023, 81(9): 1225-1233. DOI: 10.1093/nutrit/nuad021.
|
| [39] |
Dong TA, Sandesara PB, Dhindsa DS, et al. Intermittent fasting: a heart healthy dietary pattern?[J]. Am J Med, 2020, 133(8): 901-907. DOI: 10.1016/j.amjmed.2020.03.030.
|
| [40] |
Guo Y, Luo S, Ye Y, et al. Intermittent fasting improves cardiometabolic risk factors and alters gut microbiota in metabolic syndrome patients[J]. J Clin Endocrinol Metab, 2021, 106(1): 64-79. DOI: 10.1210/clinem/dgaa644.
|
| [41] |
Curtis WM, Seeds WA, Mattson MP, et al. NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson's disease[J]. Cells, 2022, 11(15): 2416. DOI: 10.3390/cells11152416.
|
| [42] |
Paoli A, Tinsley GM, Mattson MP, et al. Common and divergent molecular mechanisms of fasting and ketogenic diets[J]. Trends Endocrinol Metab, 2024, 35(2): 125-141. DOI: 10.1016/j.tem.2023.10.001.
|
| [43] |
Fan W, Chen H, Li M, et al. NRF2 activation ameliorates blood-brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation[J]. Sci Rep, 2024, 14(1): 5300. DOI: 10.1038/s41598-024-53836-0.
|
| [44] |
Brocchi A, Rebelos E, Dardano A, et al. Effects of intermittent fasting on brain metabolism[J]. Nutrients, 2022, 14(6): 1275. DOI: 10.3390/nu14061275.
|
| [45] |
Fu M, Lu S, Gong L, et al. Intermittent fasting shifts the diurnal transcriptome atlas of transcription factors[J]. Mol Cell Biochem, 2025, 480(1): 491-504. DOI: 10.1007/s11010-024-04928-y.
|
| [46] |
Eliopoulos AG, Gkouskou KK, Tsioufis K, et al. A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy[J]. Front Nutr, 2025, 12: 1524125. DOI: 10.3389/fnut.2025.1524125.
|